These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

488 related articles for article (PubMed ID: 28890870)

  • 21. [Altered serum cytokine expression profile in systemic sclerosis and its regulatory mechanisms].
    Zhu HL; DU Q; Chen WL; Zuo XX; Li QZ; Liu SJ
    Beijing Da Xue Xue Bao Yi Xue Ban; 2019 Aug; 51(4):716-722. PubMed ID: 31420628
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impaired Regulation by IL-35 in Systemic Sclerosis.
    Osuna-Gómez R; Castellví I; Mulet M; Ortiz MÀ; Brough DE; Sabzevari H; Semnani RT; Vidal S
    Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445745
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Higher levels of serum interleukin-35 are associated with the severity of pulmonary fibrosis and Th2 responses in patients with systemic sclerosis.
    Tang J; Lei L; Pan J; Zhao C; Wen J
    Rheumatol Int; 2018 Aug; 38(8):1511-1519. PubMed ID: 29846790
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Potential plasticity of T regulatory cells in pancreatic carcinoma in relation to disease progression and outcome.
    Vizio B; Novarino A; Giacobino A; Cristiano C; Prati A; Ciuffreda L; Montrucchio G; Bellone G
    Exp Ther Med; 2012 Jul; 4(1):70-78. PubMed ID: 23060925
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Elevated frequencies of CD4(+) IL-21(+) T, CD4(+) IL-21R(+) T and IL-21(+) Th17 cells, and increased levels of IL-21 in bleomycin-induced mice may be associated with dermal and pulmonary inflammation and fibrosis.
    Lei L; He ZY; Zhao C; Sun XJ; Zhong XN
    Int J Rheum Dis; 2016 Apr; 19(4):392-404. PubMed ID: 25545680
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Th17/IL-17A axis is critical for pulmonary arterial hypertension (PAH) in systemic sclerosis (SSc): SSc patients with high levels of serum IL-17A exhibit reduced lung functions and increased prevalence of PAH.
    Seki N; Tsujimoto H; Tanemura S; Ishigaki S; Takei H; Sugahara K; Yoshimoto K; Akiyama M; Kaneko Y; Chiba K; Takeuchi T
    Cytokine; 2024 Apr; 176():156534. PubMed ID: 38354516
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Imbalance of regulatory T cells to Th17 cells in IgA nephropathy.
    Lin FJ; Jiang GR; Shan JP; Zhu C; Zou J; Wu XR
    Scand J Clin Lab Invest; 2012 May; 72(3):221-9. PubMed ID: 22276947
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulatory T cells and IL-17A levels in noninfectious uveitis.
    Guedes MCE; Arroz MJ; Martins C; Angelo-Dias M; Proença RD; Borrego LM
    Graefes Arch Clin Exp Ophthalmol; 2020 Jun; 258(6):1269-1278. PubMed ID: 32200408
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interleukin-37 Inhibits the Imbalance Between T Helper 17 Cells and Regulatory T Cells in Hand, Foot, and Mouth Disease.
    Lv Y; Wang X
    J Interferon Cytokine Res; 2019 Jul; 39(7):421-427. PubMed ID: 31090483
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased frequency of circulating Th22 in addition to Th17 and Th2 lymphocytes in systemic sclerosis: association with interstitial lung disease.
    Truchetet ME; Brembilla NC; Montanari E; Allanore Y; Chizzolini C
    Arthritis Res Ther; 2011; 13(5):R166. PubMed ID: 21996293
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effector CD8+ T cells in systemic sclerosis patients produce abnormally high levels of interleukin-13 associated with increased skin fibrosis.
    Fuschiotti P; Medsger TA; Morel PA
    Arthritis Rheum; 2009 Apr; 60(4):1119-28. PubMed ID: 19333920
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dendritic cells drive profibrotic inflammation and aberrant T cell polarization in systemic sclerosis.
    Choreño-Parra JA; Cervantes-Rosete D; Jiménez-Álvarez LA; Ramírez-Martínez G; Márquez-García JE; Cruz-Lagunas A; Magaña-Sánchez AY; Lima G; López-Maldonado H; Gaytán-Guzmán E; Caballero A; Fernández-Plata R; Furuzawa-Carballeda J; Mendoza-Milla C; Navarro-González MDC; Llorente L; Zúñiga J; Rodríguez-Reyna TS
    Rheumatology (Oxford); 2023 Apr; 62(4):1687-1698. PubMed ID: 36063053
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Registry of the Spanish network for systemic sclerosis: clinical pattern according to cutaneous subsets and immunological status.
    Simeón-Aznar CP; Fonollosa-Plá V; Tolosa-Vilella C; Espinosa-Garriga G; Ramos-Casals M; Campillo-Grau M; García-Hernández FJ; Castillo-Palma MJ; Sánchez-Román J; Callejas-Rubio JL; Ortego-Centeno N; Egurbide-Arberas MV; Trapiellla-Martínez L; Gallego-Villalobos M; Sáez-Comet L; Velilla-Marco J; Camps-García MT; de Ramón-Garrido E; Esteban Marcos EM; Pallarés-Ferreres L; Hidalgo-Tenorio C; Sabio-Sánchez JM; Gómez-de la Torre R; Salvador-Cervello G; Rios-Blanco JJ; Gil-Aguado A; Vilardell-Tarrés M
    Semin Arthritis Rheum; 2012 Jun; 41(6):789-800. PubMed ID: 22169458
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differences in the induction of induced human CD4(+) CD25(+) FoxP3(+) T-regulatory cells and CD3(+) CD8(+) CD28(-) T-suppressor cells subset phenotypes in vitro: comparison of phorbol 12-myristate 13-acetate/ionomycin and phytohemagglutinin stimulation.
    Wang H; Daniel V; Sadeghi M; Opelz G
    Transplant Proc; 2013 Jun; 45(5):1822-31. PubMed ID: 23769052
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical Remission of Sight-Threatening Non-Infectious Uveitis Is Characterized by an Upregulation of Peripheral T-Regulatory Cell Polarized Towards T-bet and TIGIT.
    Gilbert RM; Zhang X; Sampson RD; Ehrenstein MR; Nguyen DX; Chaudhry M; Mein C; Mahmud N; Galatowicz G; Tomkins-Netzer O; Calder VL; Lightman S
    Front Immunol; 2018; 9():907. PubMed ID: 29774027
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Disturbed Th17/Treg Balance in Patients with Non-small Cell Lung Cancer.
    Duan MC; Han W; Jin PW; Wei YP; Wei Q; Zhang LM; Li JC
    Inflammation; 2015 Dec; 38(6):2156-65. PubMed ID: 26077695
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of CD4+CD25high regulatory T-cells and FoxP3 expression in the peripheral blood of patients with systemic lupus erythematosus.
    Atfy M; Amr GE; Elnaggar AM; Labib HA; Esh A; Elokely AM
    Egypt J Immunol; 2009; 16(1):117-26. PubMed ID: 20726328
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The predominance of Th17 lymphocytes and decreased number and function of Treg cells in preeclampsia.
    Darmochwal-Kolarz D; Kludka-Sternik M; Tabarkiewicz J; Kolarz B; Rolinski J; Leszczynska-Gorzelak B; Oleszczuk J
    J Reprod Immunol; 2012 Mar; 93(2):75-81. PubMed ID: 22370101
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of CD4+CD25+Foxp3+ Regulatory T Cells, Interleukin 10 and Transforming Growth Factor β in Newly Diagnosed Type 2 Diabetic Patients.
    Yuan N; Zhang HF; Wei Q; Wang P; Guo WY
    Exp Clin Endocrinol Diabetes; 2018 Feb; 126(2):96-101. PubMed ID: 28954308
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulatory B and T cell responses in patients with autoimmune thyroid disease and healthy controls.
    Kristensen B
    Dan Med J; 2016 Feb; 63(2):. PubMed ID: 26836805
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.